How many insider trades does FilingIQ track for ANIK?

FilingIQ tracks 291 Form 4 insider transactions for ANIK (Anika Therapeutics, Inc.), covering filings from Jan 26, 2015 onwards. 39 of those were filed in the last 90 days.

Are ANIK insiders net buyers or net sellers?

Across the full Form 4 history for ANIK, 12 transactions (4%) were open-market purchases and 29 (10%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ANIK insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ANIK in?

Anika Therapeutics, Inc. (ANIK) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $159.43M.

ANIK insider trading

NasdaqGS Healthcare

Anika Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

291

Last 90 days

Buys / sells

4% / 10%

Market cap

$159.43M

About Anika Therapeutics, Inc.

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products include Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide short-and long-term pain relief. The company's joint preservation and restoration product family comprises orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants to treat upper and lower extremity orthopedic conditions. In addition, the company offers non-orthopedic products comprising HA-based products for Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier for use after abdominal-pelvic surgeries; and Hyalomatrix for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.

Company website: www.anika.com

ANIK insider activity at a glance

FilingIQ has scored 291 insider transactions for ANIK since Jan 26, 2015. The most recent filing in our index is dated May 1, 2026.

Across the full history, 12 open-market purchases and 29 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ANIK insider trades is 55.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ANIK trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding ANIK

Trigran Investments, Inc.

$13.40M · 2.3% of AUM

Frequently asked

How many insider trades does FilingIQ track for ANIK?: FilingIQ tracks 291 Form 4 insider transactions for ANIK (Anika Therapeutics, Inc.), covering filings from Jan 26, 2015 onwards. 39 of those were filed in the last 90 days.
Are ANIK insiders net buyers or net sellers?: Across the full Form 4 history for ANIK, 12 transactions (4%) were open-market purchases and 29 (10%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ANIK insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ANIK in?: Anika Therapeutics, Inc. (ANIK) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $159.43M.

Methodology & sources

Every ANIK insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.